Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence



  • Matthew M. Yeh, MD, PhD

    Professor of Laboratory Medicine and Pathology, Adjunct Professor of Medicine;
    Director, Gastrointestinal and Hepatic Pathology Program, University of Washington, Seattle, WA, USA.


  • Ming-Lung Yu, MD, PhD

    Senior Vice President, Dean and Chair Professor, School of Medicine, College of Medicine, National Sun Yat-sen University;
    Chair Professor, Hepatitis Research Center, College of Medicine, Kaohsiung Medical University;
    Visiting staff, Hepatobiliary Section, Department of Internal Medicine, and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung;
    Adjunct Professor, National Pingtung University of Science and Technology, Pingtung, Taiwan.

  • Takumi Kawaguchi, MD, PhD

    Professor and Chairman, Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.

  • Dan Yock Young, PhD

    Chair, University Medicine Cluster;
    Senior Consultant, Division of Gastroenterology & Hepatology, Department of Medicine, National University Hospital and National University of Singapore, Singapore, Singapore.

  • Stephen A. Harrison, MD

    Visiting Professor of Hepatology, Radcliffe Department of Medicine, University of Oxford, Oxford, UK;
    Chairman- Summit Clinical Research, Chairman- Pinnacle Clinical Research, San Antonio, TX, USA.

  • Dean Tai, PhD

    Co-founder and Chief Scientific Officer of HistoIndex, Singapore, Singapore.


      Time (USA, GMT-8)
      9:00 - 9:05
      Chair (Matthew M. Yeh)
      Opening Remarks and Introduction
      9:05 - 9:25
      Ming-Lung Yu
      Treating Concomitant Disease to Mitigate NASH
      9:25 - 9:45
      Takumi Kawaguchi
      Therapeutic Strategy for NASH with a Focus in Exercise Therapy
      9:45 - 10:05
      Dan Yock Young
      Phenotype and Lean NASH
      10:05 - 10:15
      10:20 - 10:40
      Stephen A. Harrison
      NASH-The Future Looks Bright
      10:40 - 11:00
      Dean Tai
      Role of Artificial Intelligence and Machine Learning in Therapeutic Strategy of NASH
      11:00 - 11:20
      Free Discussion (Q&A)
      11:20 - 11:25
      Chair (Matthew M. Yeh)
      Concluding Remarks
© 2016-2022 OAE Publishing Inc., except certain content provided by third parties